Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

No link found between specific genes and female pattern hair loss.

5α-reductases increase epitestosterone's effect on androgen receptors.

Thai rice bran extracts, especially from Tubtim Chumphae rice, can significantly reduce the activity of hair loss genes, with x-tocopherol showing potential as an anti-hair loss product.

Asparagus racemosus root extract reduced sebum and pore size in men but not in women.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

New SRD5A2 variants may disrupt protein function, aiding diagnosis and treatment of related disorders.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Certain compounds found in edible mushrooms may help treat hair loss.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

DNMT1 may help treat hypospadias by improving cell function and preventing unwanted cell changes.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Mushroom compounds may help treat hair loss better than Finasteride.

Male pattern baldness is likely caused by multiple genes, not just 5α-reductase genes.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

New genes and pathways are important for testosterone production and male sexual development.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Gene differences may affect baldness treatment response in Korean men.